Position and orientation of phalloidin in F-actin determined by X-ray fiber diffraction analysis.
Knowledge of the phalloidin binding position in F-actin and the relevant understanding of the mechanism of F-actin stabilization would help to define the structural characteristics of the F-actin filament. To determine the position of bound phalloidin experimentally, x-ray fiber diffraction data were obtained from well-oriented sols of F-actin and the phalloidin-F-actin complex. The differences in the layer-line intensity distributions, which were clearly observed even at low resolution (8 A), produced well-resolved peaks corresponding to interphalloidin vectors in the cylindrically averaged difference-Patterson map, from which the radial binding position was determined to be approximately 10 A from the filament axis. Then, the azimuthal and axial positions were determined by single isomorphous replacement phasing and a cross-Patterson map in radial projection to be approximately 84 degrees and 0.5 A relative to the actin mass center. The refined position was close to the position found by prior researchers. The position of rhodamine attached to phalloidin in the rhodamine-phalloidin-F-actin complex was also determined, in which the conjugated Leu(OH)(7) residue was found to face the outside of the filament. The position and orientation of the bound phalloidin so determined explain the increase in the interactions between long-pitch strands of F-actin and would also account for the inhibition of phosphate release, which might also contribute to the F-actin stabilization. The method of analysis developed in this study is applicable for the determination of binding positions of other drugs, such as jasplakinolide and dolastatin 11.
Oda
Toshiro
T
Max Planck Institute for Medical Research, Department of Biophysics, Heidelberg, Germany. toda@spring8.or.jp
Namba
Keiichi
K
Maéda
Yuichiro
Y
D008841:Actin Cytoskeleton / Q000737:chemistry*; D000199:Actins / Q000737:chemistry*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001703:Biophysics / Q000379:methods*; D047630:Depsipeptides / Q000494:pharmacology; D004583:Electrons; D046911:Macromolecular Substances / Q000737:chemistry; D008958:Models, Molecular; D015233:Models, Statistical; D010590:Phalloidine / Q000737:chemistry*; D011485:Protein Binding; D011487:Protein Conformation; D012235:Rhodamines / Q000737:chemistry; D014961:X-Ray Diffraction
D000199:Actins; D000970:Antineoplastic Agents; D047630:Depsipeptides; D046911:Macromolecular Substances; D012235:Rhodamines; C422265:dolastatin 11; C057531:jasplakinolide; D010590:Phalloidine